The biosimilars market size is expected to grow from US$ 18,435.89 million in 2021 to US$ 1,36,069.53 million in 2028; it is estimated to register a CAGR of 34.8% from 2022 to 2028.
The biosimilars market is expanding rapidly due to rising demand for cost-effective biologics and the expiration of key biologic patents. These FDA-approved alternatives offer similar efficacy, boosting adoption in treating chronic diseases like cancer and autoimmune disorders. Regulatory support, increasing healthcare access, and RD advancements further drive global market growth.
Source: The Insight Partners
Canadian pharmacies not requiring prescription
Caramelized Australian Balsamic: Craving Perfection? Aussie Basket Delivers Every Time
6G Market Upcoming Opportunities, Trends and Industry Outlook 2025
3D Printing Services in Coimbatore: Choose WOL3D Coimbatore for Superior Quality
Indulge in Mutual Massage in London for Connection and Complete Relaxation
